Endothelium-dependent hyperpolarization: No longer an F-word!

Journal of Cardiovascular Pharmacology

Volumn 61, Issue 2, 2013, Pages 91-92

  Félétou, Michel ^a   Vanhoutte, Paul M ^b  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ARACHIDONATE 15 LIPOXYGENASE; BONE MORPHOGENETIC PROTEIN 4; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ICOSANOID; VANILLOID RECEPTOR 4;

BRAIN CIRCULATION; CELL COMMUNICATION; CIRCULATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION; HUMAN; HYPERPOLARIZATION; MOLECULAR BIOLOGY; NONHUMAN; PRENATAL GROWTH; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

BIOLOGICAL FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; TERMINOLOGY AS TOPIC;

EID: 84873413606     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31828197bc     Document Type: Editorial

References (12)

1. Félétou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 1988;93:515-524.
2. Chaytor AY, EvansWH, Griffith TM. Central role of heterocellular gap junction communication in endotheliumdependent relaxations of rabbit arteries. J Physiol (Lond). 1998;508:561-573.
3. Busse R, Edwards G, Félétou M, et al. EDHF: Bringing the concepts together. Trends Pharmacol Sci. 2002; 23:374-380.
4. Félétou M, Vanhoutte PM. EDHF: An update. Clin Sci. 2009;117:139-155.
5. Taylor SG, Weston AH. Endothelium-derived hyperpolarizing factor: A new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci. 1988;9:272-274.
6. Hill CE. Tudor Griffith, gap junctions and conducted vasodilatation: Electromechanical coupling back in the limelight. J Cardiovasc Pharmacol. 2013;61:93-101.
7. Wulff H, Köhler R. Endothelial small- and intermediate-conductance KCa channels: An update on their pharmacology and usefulness as cardiovascular targets. J Cardiovasc Pharmacol. 2013;61:102-112.
8. Filosa J, Yao X, Rath G. TRPV4 and the regulation of vascular tone. J Cardiovasc Pharmacol. 2013;61:113-119.
9. Campbell WB, Gauthier KM. Inducible endothelium-derived hyperpolarizing factor (iEDHF): Role of the 15-lipoxygenase-EDHF pathway. J Cardiovasc Pharmacol. In press.
10. Wong WT, Tian XY, Huang Y. Endothelial dysfunction in diabetes and hypertension: cross talk in RAS, BMP4 and ROS-dependent COX-2-derived prostanoids. J Cardiovasc Pharmacol. In press.
11. Morton JS, Davidge ST. Arterial endothelium-derived dependent hyperpolarisation: potential role in pregnancy adaptations and complications. J Cardiovasc Pharmacol. In press.
12. Bellien J, Joannides R. Epoxyeicosatrienoic acid pathway in human health and diseases. J Cardiovasc Pharmacol. In press.